stout beer
Selected indexed studies
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. (N Engl J Med, 2017) [PMID:28304224]
- In Silico Screening of Bioactive Peptides in Stout Beer and Analysis of ACE Inhibitory Activity. (Foods, 2024) [PMID:38998479]
- The Potential of Traditional Norwegian KVEIK Yeast for Brewing Novel Beer on the Example of Foreign Extra Stout. (Biomolecules, 2021) [PMID:34944422]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. (2017) pubmed
- In Silico Screening of Bioactive Peptides in Stout Beer and Analysis of ACE Inhibitory Activity. (2024) pubmed
- The Potential of Traditional Norwegian KVEIK Yeast for Brewing Novel Beer on the Example of Foreign Extra Stout. (2021) pubmed
- The origins of the Guinness stout yeast. (2024) pubmed
- The Dietetic Value of Beer and Stout. (1909) pubmed
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. (2018) pubmed
- Identification of spoilage microflora in draught beer using culture-dependent methods. (2022) pubmed
- Effect of acute beer ingestion on the liver: studies in female mice. (2015) pubmed
- The Value of Craft Beer Styles: Evidence from the Italian Market. (2023) pubmed
- Evolution: a study in bad taste? (2005) pubmed